Trials / Conditions / Polyarticular Juvenile Idiopathic Arthritis
Polyarticular Juvenile Idiopathic Arthritis
7 registered clinical trials studyying Polyarticular Juvenile Idiopathic Arthritis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases NCT07184450 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis NCT05754710 | Pfizer | — |
| Completed | Comparative Study of Leflunomide Plus Methotrexate Versus Methotrexate Monotherapy in Refractory Polyarticular NCT07428551 | Bangladesh Medical University | Phase 4 |
| Completed | An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediat NCT05411211 | AbbVie | — |
| Completed | Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS NCT04018599 | Fresenius Kabi SwissBioSim GmbH | Phase 1 |
| Completed | Surveillance of Humira in Korean JIA Patients NCT02141984 | AbbVie | — |
| Completed | Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) NCT00144625 | Chugai Pharmaceutical | Phase 3 |